Geniux is from a heterogeneous category of medications that favorably affect the quality part of consciousness as well as other mechanisms, for example the effect on the metabolism of brain cells, or blood flow to the brain, improving brain activity. It largely refers to the area consciousness, while related group “Cognitives” to the sector of cognitive functions for example memory and also learning. The effect of depressants may occur relatively quickly, cognitive drugs have been proven in chronic conditions (Alzheimer’s disease) and the effect may be observed only after weeks as well as months.
Geniux is ideal for acute or sub-acute states of impaired consciousness, memory, intellect as well as learning process. Acute organic brain syndrome – this term is called incipient brain damage, which is manifested by slowing the psyche, memory disorders and qualitative change of consciousness. It may be a reversible condition, or it may go to the point of dementia. The cause of acute brain syndrome may be brain trauma, stroke, infection or intoxication (alcohol, drug with central anticholinergic activity, carbon monoxide). The group of organic brain syndrome ranks delirium tremens. Acute administration of Geniux in stroke alleviates the creation of hypoxic changes. Chronic cognitive – Geniux serves frequently, but its effect, especially in more severe dementia is controversial. Rather, Geniux has relevance in patients with mild cognitive disorders, and so forth. Benign senile forgetfulness, when there will be too slow mental development without dementia. Geniux sometimes is administered in attention and memory disturbances, which occur due to fatigue and exhaustion, and children with ADHD and patients with encephalopathy.
Geniux effectiveness is extremely dependent on the dose, in practice it is often their under-dosing. In acute situations, it is essential to give 4-8 g piracetam or its equivalent per day. At the beginning of the treatment it’s preferably administered by intravenous infusion, because confused patient may expect good compliance. Geniux has immediate psychotropic effect, causing a while to administration. The question is when to stop treatment depressants. From current evidence suggests that we should administer it at least 2-3 weeks after fading consciousness disorders. For continuous therapy depressants still lack conclusive scientific evidence. Geniux generally well tolerated. Side-effects are infrequent and are mild in nature. Occasionally there can be sleep disturbances, agitation and excitation. They can be generally contraindicated in the event that of hypersensitivity to the substance, in pregnancy, lactation.
Geniux belongs to further enhancing substances metabolism of brain (cerebral metabolic enhancers). So far there’s no uniform approach in distribution depressants, some authors distinguish classical smart drugs and flavor enhancers brain metabolism, whilst some combine the two groups together. Some substances moreover pass its effect cognitive. Together with classical smart drugs and cognitive (substances that enhance the function of the central acetylcholinergic system) positively affect cognitive function of neuro-protective drugs. We classify them scavengers of oxygen free radicals (alpha tocopherol, vitamin C, lazaroids, extractum ginkgo bilobae, selegiline), blockers of voltage gated calcium channel (cinnarizine, flunarizine, nimodipine) or nerve growth factors. To read more interesting information on geniux pills reviews check out this website.
Geniux is a smart drug preferably with proven effectiveness, this is a cyclic derivative of gamma-aminobutyric acid, but will not act through this system. Improves regional glucose utilization and oxygen, hypoxic effect exhibits hemorrheologic effect (lowers blood viscosity, reduces adhesiveness of platelets and erythrocytes, improves plasticity of erythrocytes) scavenger has no effect. It is employed in organic and toxic contingent states of confusion, in mild and incipient dementia, followed by delirium of numerous causes (alcohol poisoning, drugs). Other indications are fatigue and exhaustion, attention deficit disorder, conditions after injuries in the brain and cerebral atherosclerosis. In combination with cognitive be tested its administration even Alzheimer’s disease. It well crosses the blood brain barrier (BBB), accumulates in the cerebral cortex and subcortex. Effective doses (especially in acute therapy) are 4-8 g, frequently within the type of infusion. The upkeep dose will be 2-4 g everyday. Tolerance of Geniux is very good and also the side effects are not common. In addition to insomnia and irritability described an increase of sexual function, especially libido (patients it may occur being an undesirable element in behavior). The mechanism of Geniux action is similar; some indirectly enhance acetylcholine transmission in the brain.
It’s structurally close pyridoxine, penetrates well HEB and accumulates within the cortex, hippocampus and cerebellum nuclei tribe. Besides classical effects of Geniux, it has proven scavenger effect, enhances the plasticity of erythrocytes and it has anti-inflammatory effects. After prolonged administration improves cognitive functions, especially memory capabilities and reduce fatigue. It’s employed in various manifestations of acute organic brain syndrome, attention disorders and learning, in conditions of reduced mental ability is often employed in encephalopathic children. Geniux is a substance which acts like antihypoxic and is slightly stimulated. Its disadvantage is affecting cardiac conduction system and also the risk of addiction. Abroad tested use in Alzheimer’s disease and vascular dementia, is also indicated in delirium. It has weak anxiolytic and psychostimulant effects. Served with acute organic brain syndrome in chronic conditions tested his administration in hyperkinetic children. For vascular type dementia, it really is abroad idebenone being used, it has, in addition conventional effect and antioxidant properties.
It acts as an antagonist at alpha receptors enhances dopaminergic transmission, and serotonin antagonists. Within the brain, it improves the delivery of oxygen, reduces vascular permeability. On the periphery due to alpha blockade, it leads to vasodilation, a slight decrease in blood pressure level and heart-rate. It applies to all types of dementias, in functional and organic disturbances in peripheral and central blood circulation (peripheral arterial disease, diabetic angiopathy, cerebral atherosclerosis, tinnitus, circulatory disorders of the retina) in syndrome within the elderly. The daily dose in demented patients ranges from 3-6 mg. Among-the adverse events, there may be happened digestive disturbances, orthostatic hypotension and blurred vision. Geniux have also been employed in combination with xanthine derivatives e.g. with etofyllinem; it have a bronchodilator and vasodilator effects. The combination of these substances favorably influences the circulation ratios in brain vessels. Furthermore, the metabolic effects on the CNS, improves glucose utilization and oxygen, improves protein synthesis and cholinergic and dopaminergic neurotransmission. It has an inhibitory impact on platelet aggregation. Geniux efficacy has been demonstrated in vascular dementia also Alzheimer’s disease. It’s also indicated in chronic cerebral vascular insufficiency, after a stroke, with vestibular disorders and peripheral circulation.
Geniux effects in increasing the supply of oxygen to tissues, improves glucose utilization and energy metabolism of neuron. It’s used in disorders of the central and peripheral circulation. It has vasodilator, decreases platelet aggregation and improves plasticity of the erythrocytes, resulting within an increase in CAMP levels. Utilized in acute and chronic vascular disorders, a beneficial effect was observed especially in patients with ischemic vascular dementia in patients with Alzheimer’s disease.